Takeda Acquires Ariad for US$5.2 B to Add Depth to Oncology Portfolio
By Subham Nandi & Vipul Sikka
Pharma Deals Review: Vol 2017 Issue 1 (Table of Contents)
Published: 28 Jan-2017
DOI: 10.3833/pdr.v2017.i1.2220 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Takeda’s oncology portfolio gains momentum with the acquisition of Ariad for US$5...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS